CCM

Concord Medical Services Holdings Limited (NYSE:CCM) is a Chinese healthcare company founded in 1997 and headquartered in Beijing. The company operates a network of radiotherapy and diagnostic imaging centers across China, providing specialized cancer treatment services through partnerships with hospitals and its own facilities. Since going public in 2009, Concord has focused on expanding access to advanced cancer treatment technologies in China's growing healthcare market, though it has faced significant financial challenges in recent years with consistent operating losses and declining revenues.